UPL Limited has informed the Exchange about Investor Presentation
UPL Limited, Uniphos House, C.D. Marg, 11th Road, Madhu Park, Khar (West), Mumbai – 400052, India
w: www.upl-ltd.com e: contact@upl-ltd.com t: +91 22 6856 8000
November 6, 2025
BSE Limited Mumbai
National Stock Exchange of India Ltd. Mumbai
SCRIP CODE – 512070
SYMBOL: UPL
Sub.: Investor presentation for Q2 and H1 FY 2026
Dear Sir/Madam,
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing the investor presentation for the quarter and half year ended September 30, 2025.
We request you to take the above information on records.
Yours faithfully, For UPL Limited
Sandeep Deshmukh Company Secretary and Compliance Officer (ACS-10946)
Encl.: As above
Cc.: 1. London Stock Exchange 2. Singapore Stock Exchange
Registered Office: 3-11, GIDC, Vapi, Valsad - 396 195, Gujarat, India. P +91 260 2432716 CIN: L24219GJ1985PLC025132
UPL Limited
Consolidated Financial Results and Business Update Q2 and H1FY26
Investor Presentation 06th November 2025
Safe Harbor Statement
This document contains certain forward-looking statements with respect to the financial condition, results of operations and business of
UPL Limited (UPL) and certain of the plans and objectives of UPL with respect to these items. Examples of forward-looking statements
include statements made about our strategy, estimates of sales growth, future EBITDA and future developments in our organic business.
Forward-looking statements can be identified generally as those containing words such as “anticipates”, “assumes”, “believes”, “estimates”,
“expects”, “should”, “will”, “will likely result”, “forecast”, “outlook”, “projects”, “may” or similar expressions. By their nature, forward-looking
statements involve risk and uncertainty because they relate to future events and circumstances and there are many factors that could
cause actual results and developments to differ materially from those expressed or implied by these forward-looking statements. These
factors include, but are not limited to, domestic and global economic and business conditions, the successful implementation of our
strategy and our ability to realize the benefits of this strategy, our ability to develop and market new products, changes in legislation, legal
claims, changes in exchange and interest rates, changes in tax rates, raw materials and employee costs, our ability to identify and
complete successful acquisitions and to integrate those acquisitions into our business, our ability to successfully exit certain businesses or
restructure our operations, the rate of technological changes, political, economic and other developments in countries where UPL
operates, industry consolidation and competition. As a result, UPL’s actual future results may differ materially from the plans, goals and
expectations set forth in such forward-looking statements. For a discussion of factors that could cause future results to differ from such
forward-looking statements, please refer to the Risk Management Section of our Annual Report.
2
Agenda
Key Presenters Today…
UPL Limited
Bikash Prasad Group CFO
UPL Corp
Mike Frank CEO
…and other senior management
UPL SAS Ravi Cherukuri CEO
Advanta Bhupen Dubey CEO
SUPERFORM Raj Tiwari CEO
3
Agenda
Content
I. Financial and Business Segment
Key Macro Trends for the Quarter
Key Highlights for the Quarter
Q2 and H1FY26 Performance Update
Performance Dashboard Summary
P&L Analysis: Revenue, Contribution, EBITDA and PATMI
Balance Sheet Analysis: Working Capital, Net Debt and Leverage Ratios
Cash Flow Analysis
Platform-wise Q2 and H1FY26 Performance Update
II. Summary (FY26 Outlook and Guidance)
III. Others (Non-Financial Enablers)
Manufacturing and R&D Capabilities
Board of Directors
5
6
7–23
7–8
9–18
19–22
23
24–30
31–33
34–43
44–50
4
UPL Limited | Q2 and H1FY26
Key Macro Trends for the Quarter
▪
Stable demand in crop protection globally
▪ Continued US tariff uncertainties
▪
Low commodity prices (e.g., soy, corn) led farm-income stress in Brazil, LATAM
▪ Unfavorable weather-related impact in India in second quarter
▪
Softened SOFR rate
⚫
⚫
⚫
⚫
⚫
5
UPL Limited Q2FY26 | Corporate Update
Key Highlights for the Quarter
1
2
3
Corporate realignment
Successful integration of post-harvest business (DECCO) with Advanta
Rights issue
$200 Mn balance from final call received in Sep’25
Ratings outlook
Upgraded from “negative” to “stable” by all three global ratings agencies (S&P, Fitch, Moody’s), on account of strong recovery post FY24
6
UPL Limited Q2 and H1FY26 | Performance Dashboard Summary
PATMI Improved by ~₹1,000 cr in Q2, Driven by Broad-based Growth in EBITDA and Financial Discipline; Strong H1 with Positive PATMI (up by ~₹1,300 cr vs. LY)
Q2
Revenue
₹12,019 cr V: +7% | P: (2%) | E: +3%
Contribution
₹5,041 cr
Margin
41.9%
EBITDA
Margin
₹2,205 cr
18.3%
PBT
₹784 cr
I
II
III
IV
vs. LY
| +8%
| +21% | +420 bps
| +40% | +410 bps
| (₹447 cr)
in Q2LY
V
PATMI Op. PATMI(1)
₹553 cr
₹411 cr
(1) Operational PATMI (adjusted for exceptional items)
| (₹443 cr) in Q2LY | (₹434 cr) in Q2LY
H1
₹21,235 cr V: +3% | P: (1%) | E: +3%
vs. LY
| +5%
₹9,042 cr
42.6%
₹3,508 cr
16.5%
₹594 cr
₹465 cr
₹331 cr
| +16% | +410 bps
| +29% | +300 bps
| (₹902 cr)
in H1LY
| (₹827 cr) in H1LY | (₹769 cr) in H1LY
7
UPL Limited Q2 and H1FY26 | Performance Dashboard Summary
Lower net debt and net working capital days vs. LY, with significant de-gearing, implying continued focus on balance sheet strengthening
as on 30th Sep’25
vs. LY
Net Debt
₹23,802 cr
$2,681 Mn
| ₹27,531 cr | $3,285 Mn
Net Debt / EBITDA(1)
2.7x
Net Debt / Equity
0.6x
| 5.4x
| 0.9x
Lower by >₹3,700 cr (>$600 Mn); on including perpetual bonds as debt in Sep’24, the net debt reduction is ~$1.0 Bn
Improved; on including perpetual bonds as debt in Sep’24, LY net debt to EBITDA is 6.1x
Improved; on including perpetual bonds as debt in Sep’24, LY net debt to equity is 1.1x
NWC Days(1)
118 Days
NWC (₹)
₹15,463 cr
| 123 Days | ₹14,829 cr
Improved by ~5 days
I
II
III
IV
(1) Calculated on TTM basis
8
P&L Analysis
UPL Limited Q2 and H1FY26 | Performance Summary
Higher volume, accretive margin led strong performance; broad-based EBITDA growth across all platforms; financial discipline led overall improved PATMI
Particulars (₹ cr)
Revenue
Contribution
Contribution Margin (%)
SG&A
EBITDA
EBITDA Margin (%)
PBT
PATMI
NWC (Days)
Net Debt to EBITDA
Q2FY25A
11,090
Q2FY26A
12,019
4,180
37.7%
2,604
1,576
14.2%
(447)
(443)
123
5.4x
5,041
41.9%
2,836
2,205
18.3%
784
553
118
2.7x
vs. LY
8%
21%
420 bps
9%
40%
410 bps
1,231
996
(5)
improved
H1FY25A
20,157
H1FY26A
21,235
7,764
38.5%
5,043
2,721
13.5%
(902)
(827)
123
5.4x
9,042
42.6%
5,535
3,508
16.5%
594
465
118
2.7x
vs. LY
5%
16%
410 bps
10%
29%
300 bps
1,496
1,292
(5)
improved
Revenue • V: +7% | P: (2%) | F: +3% • Led by UPL Corp and
Advanta volumes, partially offset by UPL SAS; steady SUPERFORM revenue
Q2 Drivers
Contribution and margin •
Improved mix, higher capacity utilization and lower input cost
EBITDA • Driven by higher volumes and accretive contribution margin
PATMI •
Increased by ~₹1,000 cr vs. LY, led by EBITDA, lower finance cost, Fx, among others
NWC days • Lower by 5 days vs. LY
10
UPL Limited Q2 and H1FY26 | P&L Statement
Higher volume, accretive margin led strong performance; broad-based EBITDA growth across all platforms; financial discipline led overall improved PATMI
Particulars (₹ cr)
Revenue
Contribution
Contribution Margin (%)
SG&A
EBITDA
EBITDA Margin (%)
Other (income)
Depreciation & amortisation expenses
Net exchange difference
Share of loss/ (profit) from associates and JVs
Exceptional items
Net finance costs
PBT
Taxation
PAT
Non-controlling interests
PATMI
Operational PATMI
Q2FY25
Q2FY26
Change YoY
H1FY25
H1FY26
Change YoY
11,090
12,019
4,180
38%
2,604
1,576
14%
(39)
697
375
135
8
847
(447)
137
(585)
(142)
(443)
(434)
5,041
42%
2,836
2,205
18%
(15)
771
235
54
(142)
518
784
172
612
59
553
411
8%
21%
420 bps
9%
40%
410 bps
24
11%
(37%)
(60%)
(150)
(39%)
1,231
25%
1,197
201
996
845
20,157
21,235
7,764
39%
5,043
2,721
13%
(63)
9,042
43%
5,535
3,508
17%
(53)
1,357
1,502
518
167
57
1,587
(902)
210
(1,112)
(285)
(827)
(769)
413
36
(133)
1,149
594
158
436
(29)
465
331
5%
16%
410 bps
10%
29%
300 bps
10
11%
(20%)
(79%)
(190)
(28%)
1,496
(24%)
1,548
256
1,292
1,100
11
UPL Limited Q2 and H1FY26 | Revenue: Platform-wise Analysis
Strong Q2 performance led by UPL Corp and Advanta; Q2 driven recovery in H1 revenue vs. LY
Q2 Platform-wise Revenue(1)(3) (₹ cr)
YoY
+8%
+12%
(10%)
+26%
+1%
11,090
12,019
7,676
8,625
UPL Ltd.
UPL Corp
UPL SAS
Advanta
SUPERFORM
1,014
911
1,323
1,669
2,777
2,799
H1 Platform-wise Revenue(1)(3) (₹ cr)
YoY
+5%
+6%
+2%
+23%
+4%
20,157
21,235
13,816
14,582
UPL Corp
• Q2: V: +10% | P: (2%) | F: +4% • Higher vol. in Americas, supported by Africa and APAC • North America led by herbicide volume, Brazil through mancozeb, LATAM driven mainly by Argentina recovery
• Steady Europe revenue, despite one-time higher
Proxanil® sales LY
• H1 led by strong North America performance, and Q2
recovery in most regions
UPL SAS
• Q2: V: (7%) | P: (3%) | F: 0% • Unfavorable weather-led, impacting mainly herbicides • H1 positive, with Q2 offsetting Q1 gains
Advanta(4)
• Q2: V: +14% | P: +10% | F: +4% • Higher volumes in field corn (India, Argentina, other Latin American countries, Indonesia), sunflower in Argentina
• Sequentially improved Q2 led H1
UPL Ltd.
UPL Corp
UPL SAS
Advanta
SUPERFORM
2,017
2,048
2,489
3,065
5,133
5,357
SUPERFORM
• Q2: V: +6% | P: (5%) | F:0% • SSC(2) (+18% vs. LY) led by volume, driven by contract manufacturing; non-agchem share ~25% vs. ~20% LY
FY25
FY26
(1) This is for UPL Limited total and four “pure-play” platforms, with applicable proforma adjustments, and without considering group elimination; (2) SSC: Super Specialty Chemicals (specialty chemicals sales externally); (3) Advanta’s financial statements for the current period and comparative period last year have been restated to reflect the acquisition of Decco under common control; (4) Revenue variances are for Advanta standalone only
12
UPL Limited Q2 and H1FY26 | Revenue: Region-wise Analysis
Strong Q2 driven by Americas; H1 growth driven by key regions
349
4
89
12,019
• Higher volume in fungicides (mancozeb in Brazil)
Q2 Region-wise Revenue (₹ cr)
11,090
651
+13%
Q2FY25
LATAM
+63%
NAM
flat
Europe
+6%
India
(164)
(6%)
ROW
Q2FY26 Revenue (₹ cr)
5,693
907
1,371
1,660
2,388
H1 Region-wise Revenue (₹ cr)
20,157
393
+5%
H1FY25
LATAM
450
114
479
+25%
NAM
+4%
Europe
+14%
India
(358)
(8%)
ROW
H1FY26 Revenue (₹ cr)
8,095
2,244
2,907
3,922
4,067
Latin America
North America
Europe
India
and herbicides
• Argentina recovery, led by herbicides, corn, sunflower • H1 improvement led by Q2 crop protection
• Driven by herbicide volumes • Strong Q2 led improved H1
• Steady Q2 revenue • H1 positive from strong Q1
• Seeds (e.g., field corn) growth, offset partially
by crop protection decline • H1 strong despite moderate Q2
ROW
• Lower revenue vs. LY
Q2FY26
21,235
H1FY26
13
UPL Limited Q2 and H1FY26 | Contribution Analysis: Platform-wise
Strong contribution growth, broad-based margin accretion across all platforms
Q2 Platform-wise Contribution(1)(2) (₹ cr)
YoY
+21%
+27%
+5%
+29%
+18%
4,180
5,041
3,024
2,376
UPL Corp
• Lower input cost and higher capacity utilization
304
319
750
964
591
699
UPL Ltd.
UPL Corp
UPL SAS
Advanta
SUPERFORM
CM%
38%
42%
31%
35%
30%
35%
57%
58%
21%
25%
UPL SAS
• Margin accretion led by improved product mix
(e.g., Centurion® EZ, Canora® EZ)
H1 Platform-wise Contribution(1)(2) (₹ cr)
YoY
+16%
+21%
+18%
+22%
+15%
Advanta
• Revenue led growth (mainly in field corn
and sunflower); steady contribution margin
9,042
7,764
4,215
5,096
587
691
1,434
1,744
1,167
1,337
UPL Ltd.
UPL Corp
UPL SAS
Advanta
SUPERFORM
CM% FY25
39%
43%
FY26
31%
35%
29%
34%
58%
57%
23%
25%
SUPERFORM
• Driven by improved mix (including higher SSC(3) share),
lower input costs
(1) This is for UPL Limited total and four “pure-play” platforms, with applicable proforma adjustments, and without considering group elimination; (2) Advanta’s financial statements for the current period and comparative period last year have been restated to reflect the acquisition of Decco under common control; (3) SSC: Super Specialty Chemicals (specialty chemicals sales externally)
14
UPL Limited Q2 and H1FY26 | EBITDA Analysis: Platform-wise
Strong Q2 and H1 EBITDA growth through broad-based performance across all platforms
Q2 Platform-wise EBITDA(1)(2) (₹ cr)
YoY
+40%
+69%
+2%
+57%
+24%
2,205
1,576
1,260
745
203
207
272
429
307
380
UPL Corp
• Led by volume and higher contribution margin
UPL Ltd.
UPL Corp
UPL SAS
Advanta
SUPERFORM
UPL SAS
• Steady contribution led EBITDA
EBITDA%
14%
18%
10%
15%
20%
23%
21%
26%
11%
14%
H1 Platform-wise EBITDA(1)(2) (₹ cr)
Advanta
• Driven by higher volumes
YoY
+29%
+56%
+24%
+32%
+15%
3,508
2,721
1,646
1,058
372
461
544
717
619
713
SUPERFORM • Led by contribution accretion
UPL Ltd.
UPL Corp
UPL SAS
Advanta
SUPERFORM
EBITDA% FY25
13%
17%
FY26
8%
11%
18%
23%
22%
23%
12%
13%
(1) This is for UPL Limited total and four “pure-play” platforms, with applicable proforma adjustments, and without considering group elimination; (2) Advanta’s financial statements for the current period and comparative period last year have been restated to reflect the acquisition of Decco under common control
15
UPL Limited Q2FY26 | EBITDA Analysis
Volume led EBITDA growth, supported by favorable Fx
EBITDA Bridge (Q2FY25 vs. Q2FY26) (₹ cr)
129
(68)
(232)
800
Revenue impact
Cost impact
2,205
1,576
Q2FY25
Volume
Price, FX
COGS
SG&A
Q2FY26
Volume • Led by crop protection (Americas), supported by seeds in key regions and SUPERFORM SSC(1)
Price, Fx • Pricing pressure, mainly in crop protection/ agchem products
• Favorable Fx impact of ~3%
COGS • Favorable input cost and higher
capacity utilization in crop protection, offset by higher sales volumes
SG&A •
In line with revenue growth, focused spend on A&P for new launches
Q2 Drivers
(1) SSC: Super Specialty Chemicals (specialty chemicals sales externally)
16
UPL Limited Q2FY26 | PATMI Analysis
PATMI improvement of ~₹1,000 cr vs. LY, mainly through higher EBITDA, lower finance cost, Fx, among others
Q2FY26 PATMI(1) Bridge (₹ cr)
Q2FY25
EBITDA
(443)
629
74
D&A
140
24
35
81
201
150
330
553
NFC
FX/ Hedging cost Oth. inc./ loss
Tax
A.I.
NCI
Excep. cost
Q2FY26
NFC • Debt repayment of ~$250 Mn in Mar, lower finance cost (SOFR), lower factoring value, rating outlook upgrade
FX Gain / Loss • Favorable currency
movement in specific geographies
Q2 Drivers
Associate Income / JV • Reduction in losses vs. LY
Non-controlling Interest • Improved profitability across platforms; increased minority stake in Advanta (post Alpha Wave investment)
Exceptional Cost • VAT reversal in Brazil, partially offset by restructuring cost
(1) D&A: Depreciation and Amortization | NFC: Net Finance Cost | Fx: Exchange impact | A.I.: Associated income/ joint ventures | NCI: Non-controlling interests
17
UPL Limited H1FY26 | PATMI Analysis
PATMI improvement of ~₹1,300 cr vs. LY, driven by higher EBITDA, lower finance cost, Fx, among others
H1FY26 PATMI(1) Bridge (₹ cr)
105
10
52
438
131
256
190
465
NFC
FX/ Hedging cost Oth. inc./ loss
Tax
A.I.
NCI
Excep. cost
H1FY26
H1FY25
EBITDA
(827)
787
D&A
(145)
NFC • Debt repayment of ~$250 Mn in Mar, lower finance cost (SOFR), lower factoring value, rating outlook upgrade
FX Gain / Loss • Favorable currency
movement in specific geographies
H1 Drivers
Associate Income / JV • Reduction in losses vs. LY
Non-controlling Interest • Improved profitability across platforms; increased minority stake in Advanta (post Alpha Wave investment)
Exceptional Cost • VAT reversal in Brazil, partially offset by restructuring cost
(1) D&A: Depreciation and Amortization | NFC: Net Finance Cost | Fx: Exchange impact | A.I.: Associated income/ joint ventures | NCI: Non-controlling interests
18
Balance Sheet Analysis
UPL Limited Q2FY26 | Balance Sheet Analysis
Working capital in line with seasonality; lower cash balance mainly due to redemption of perpetual bond in Q1
Particulars (₹ cr)
Uses of Capital
Fixed Capital
Right-of-use assets
Working capital
Cash & Bank balance (incl. current investments)
Others
Total
Sources of Capital
Total Equity
Non-controlling interests (incl. perp bond)
Short-term debt
Long-term debt
Right of use lease liabilities
Total
Sep’24
Mar’25
Sep’25
Change vs. Mar’25
41,524
1,310
14,829
4,312
2,858
41,935
1,324
6,764
9,856
3,048
43,652
1,385
15,463
4,760
2,472
64,834
62,927
67,731
23,946
29,214
7,670
9,789
22,054
1,375
64,834
8,614
5,451
18,263
1,385
62,927
31,894
5,816
11,353
17,209
1,460
67,731
1,717
61
8,699
(5,096)
(576)
4,804
2,680
(2,798)
5,902
(1,054)
75
4,804
• Working capital increase vs. Mar’25; however, in line with seasonality, resulting in increased net debt
• Cash balance reduction from redemption
of perpetual bonds in May’25, and utilization for working capital
• Equity increase from positive PATMI and rights
issue (~$200 Mn; money received)
(1) Includes investments
20
UPL Limited Q2FY26 | Working Capital Analysis
Net working capital days improved by ~5 days vs. LY; increase in receivables and inventory in line with Q2 growth and anticipated H2 plans, respectively
Inventory
Receivables
Payables
Net Working Capital
Sep’24
Sep’25
Sep’24
Sep’25
Sep’24
Sep’25
Sep’24
Sep’25
₹14,106 cr
₹16,193 cr
₹16,062 cr
₹19,021 cr
₹15,338 cr
₹19,751 cr
₹14,829 cr
₹15,463 cr
DIO
117
124
DSO
133
146
DPO
127
151
Net Days
123
118
Q2FY25
Q2FY26
Q2FY25
Q2FY26
Q2FY25
Q2FY26
Q2FY25
Q2FY26
DIO Higher by ~7 Days in anticipation for upcoming season in H2
DSO Increased by ~13 Days due to higher sales vs. LY
Net Working Capital lowered by ~5 Days vs. Sep 24
Q2 Drivers
Note: As a risk management measure, receivables are factored on non-recourse basis to banks; non-recourse receivables factoring as of 30 Sep’25: $553 Mn (~₹4,911 cr), 30 Sep’24: $558 Mn (~₹4,679 cr)
21
UPL Limited Q2FY26 | Net Debt Analysis
Net debt lower by >$600 Mn (adjusted for perpetual bonds, lower by $1.0 Bn); significant improvement in gearing ratios vs. LY
Particulars (₹ cr)(1)
Sep’24 Mar’25
Sep’25
vs. Sep’24
vs. Mar’25
Particulars ($ Mn)
Sep’24 Mar’25
Sep’25
vs. Sep’24
vs. Mar’25
Gross Debt(2)
31,843
23,714
28,562
(3,281)
4,848
Gross Debt(2)
3,800
2,774
3,217
(583)
442
Cash and Cash Equivalent(3)
4,312
9,856
4,760
448
(5,096)
Cash and Cash Equivalent(3)
515
1,153
536
21
(617)
Net Debt
27,531
13,858
23,802
(3,729)
9,945
Net Debt
3,285
1,621
2,681
(605)
1,059
Net Debt Adj. for Currency Impact
27,531
22,463
(5,068)
Net debt to EBITDA
5.4x
1.7x
2.7x
• Lower net debt vs. Sep’24, led by lower gross debt (debt pre-payment
$250Mn) and higher cash position (adjusted for two capital transactions, perpetual bond redemption)
Net debt to Equity
0.9x
0.4x
0.6x
• Higher net debt vs. Mar ’25 due to perpetual bond redemption (as above)
and increased working capital due to seasonality
• On inclusion of perpetual bonds as debt in Sep’24, net debt to equity is 1.1x and net debt to EBITDA is 6.1x; similarly, the corresponding figures for Mar’25 are 0.5x and 2.1x
(1) USD/ INR depreciated from 83.80 as on 30th Sep 2024 to 88.79 as on 30th Sep 2025; (2) Gross Debt includes all external debt including short-term and long-term; (3) Includes liquid investment of ₹402 cr ($48Mn) as of Sep’24 and ₹608 cr ($68Mn) in Sep’25
22
UPL Limited Q2 and H1FY26 | Cash Flow Analysis
FCFE in line with historical trend; adjusted for changes in working capital (seasonality effect), FCFE has improved by >₹1,900 cr vs. LY
Particulars (₹ cr)
EBITDA ±non-cash items(1)
Changes in working capital
Other non-current & current assets, liab. & FCTR
Net Operating cash flow
Income tax paid
Capex
Investments
Free cash flow to firm (FCFF)
Net interest paid
Free cash flow to equity (FCFE)(2)
FCFE adjusted for “changes in working capital” (seasonal)(2)
H1 Sep’23
H1 Sep'24
H1 Sep'25
Change vs. LY
2,385
(10,727)
(909)
(9,251)
(840)
(1,077)
(416)
(11,584)
(1,233)
(12,816)
(2,089)
2,244
(4,890)
461
(2,185)
(547)
(526)
(182)
(3,440)
(1,620)
(5,060)
(170)
3,153
(8,530)
581
(4,796)
33
(984)
181
(5,566)
(1,231)
(6,797)
1,733
908
(3,640)
121
(2,611)
580
(458)
363
(2,126)
389
(1,737)
1,903
Improvement driven by higher EBITDA (₹908 cr), lower net interest paid (by ₹389 cr) and investment income (₹363 cr)
(1) Non-cash items mainly include ECL, provisions, fair-value change in investments, share based payments, etc.; (2) This is operational cash flow and excludes proceeds from current borrowings/ rights issue / repayment of perpetual bond and dividend payment. Cash and cash equivalent include current investment
23
Platform Updates
UPL Corp Q2 and H1FY26 | Performance Summary
Strong revenue growth and contribution margin accretion led EBITDA expansion in Q2; continued momentum in H1
Particulars (₹ cr)
Revenue
Contribution
Contribution Margin (%)
SG&A
EBITDA
EBITDA Margin (%)
Note: Above financials are after considering proforma adjustments
Revenue • V: +10%; P: (2%); F: +4% • Volume led growth in North America,
Latin America (Brazil fungicides, Argentina recovery)
Q2 Drivers
Q2FY25A
Q2FY26A
vs. LY
H1FY25A
H1FY26A
vs. LY
7,676
2,376
31.0%
1,631
745
9.7%
8,625
3,024
35.1%
1,764
1,260
14.6%
12%
27%
410 bps
8%
69%
490 bps
13,816
14,582
4,215
30.5%
3,157
1,058
7.7%
5,096
34.9%
3,450
1,646
11.3%
6%
21%
440 bps
9%
56%
360 bps
Contribution and margin • Led by lower input cost, higher capacity utilization
EBITDA • Driven by contribution margin
improvement
25
UPL Corp Q2 and H1FY26 | Region-wise Analysis
Strong Q2 performance in the Americas region, H1 driven by growth in all regions, mainly North America
in ₹ cr
7,676
438
327
(13)
177
8,625
in ₹ cr
13,816
141
391
48
159
14,582
+10%
Q2FY25
Latin America
Q2 Rev (₹ cr)
4,884
+79%
NAM
742
(1%)
Europe
1,244
+12%
ROW
1,711
Q2FY26
H1FY25
Latin America
+2%
H1 Rev (₹ cr)
7,040
+26%
NAM
1,904
+2%
Europe
2,643
+6%
ROW
2,898
H1FY26
Latin America • Brazil: fungicide volume growth
North America • Led by herbicide volume growth
Europe • Steady revenue despite
ROW • APAC led by Indonesia and Japan,
led by mancozeb (Unizeb®); price pressure in acetamiprid (Sperto®)
(s-metolachlor, metribuzin) • Momentum continues in H1
fungicide volume normalization vs. LY
supported by Africa
• H1 positive vs. LY from strong Q2
• Argentina recovery, partially
softened by lower exposure in Bolivia and Mexico
Q2 Drivers
• H1 positive vs. LY from strong Q2
26
UPL SAS Q2 and H1FY26 | Performance Summary
Strong EBITDA delivery despite unfavorable weather led disruptions
Particulars (₹ cr)
Revenue
Contribution
Contribution Margin (%)
SG&A
EBITDA
EBITDA Margin (%)
Q2FY25A
Q2FY26A
1,014
304
30.0%
101
203
911
319
vs. LY
(10%)
5%
35.0%
500 bps
112
207
10%
2%
H1FY25A
H1FY26A
vs. LY
2,017
587
29.1%
215
372
2,048
691
33.7%
230
461
2%
18%
460 bps
7%
24%
20.0%
22.7%
270 bps
18.4%
22.5%
410 bps
Note: Above financials pertain to India Crop Protection business only based on proforma adjustments and exclude ‘Nurture’
Revenue • V: (7%); P: (3%); F: 0% • Volume decline due to
unfavorable weather conditions
Contribution and margin • Led by improved mix
(including new launches)
EBITDA • Driven by higher contribution margin
Q2 Drivers
27
Advanta(1) Q2 and H1FY26 | Performance Summary
Field corn and sunflower led growth drove significant improvement in Q2 EBITDA margin vs. LY
Particulars (₹ cr)
Revenue
Contribution
Contribution Margin (%)
SG&A
EBITDA
EBITDA Margin (%)
Q2FY25A
Q2FY26A
vs. LY
H1FY25A
H1FY26A
vs. LY
1,323
750
56.7%
477
272
1,669
964
57.7%
535
429
26%
29%
100 bps
12%
57%
2,489
1,434
57.6%
890
544
20.6%
25.7%
510 bps
21.9%
3,065
1,744
56.9%
1,028
717
23.4%
23%
22%
(70 bps)
15%
32%
150 bps
Revenue(2) • V: +14% | P: +10% | F: +4% • Led by corn (India, Argentina, other Latin America countries, Indonesia), sunflower (Argentina)
• Robust Q2 and H1 growth in the post-harvest Decco business
Q2 Drivers
Contribution and margin • Revenue led growth; margin accretion
EBITDA • Led by revenue growth and
from corn and sunflower
• Q1 higher production cost led impact
on H1 performance
contribution margin improvement • Stronger Q2 vs. Q1, driving accretive
H1 margin
(1) Advanta’s financial statements for the current period and comparative period last year have been restated to reflect the acquisition of Decco under common control; (2) Revenue variances are for Advanta standalone only
28
Advanta(1) Q2 and H1FY26 | Region-wise Analysis
Key growth led by Americas and India
118
9
1,669
240
(21)
308
15
3,065
320
(67)
1,323
2,489
+37%
+23%
(18%)
+26%
+34%
+24%
(35%)
+17%
Q2FY25
Americas
Asia / Africa
Australia
Europe
Q2FY26
H1FY25
Americas
Asia / Africa
Australia
Europe
H1FY26
Q2 Rev (₹ cr)
894
638
94
43
H1 Rev (₹ cr)
1,248
1,589
126
102
Americas • Field corn (Argentina, other Latin American countries) and sunflower (Argentina)
Asia / Africa • Led by field corn (India, Indonesia)
Australia • Canola revenue impacted due to drought, partially mitigated by early sorghum sales
Europe • Robust growth despite
off season
Q2 Drivers
(1) Advanta’s financial statements for the current period and comparative period last year have been restated to reflect the acquisition of Decco under common control
29
SUPERFORM Q2 and H1FY26 | Performance Summary
Strong Q2 EBITDA, led by improved mix and favorable input cost, along with higher growth in the SSC(1) segment
Particulars (₹ cr)
Revenue
Contribution
Contribution Margin (%)
SG&A
EBITDA
EBITDA Margin (%)
Revenue • V: +6% | P: (5%) | F: 0% • SSC(1) (+18% vs. LY) led by volume • Non-agchem revenue share: ~25% vs.
~20% LY
Q2 Drivers
Q2FY25A
Q2FY26A
vs. LY
H1FY25A
H1FY26A
vs. LY
2,777
591
21.3%
284
307
2,799
699
25.0%
319
380
1%
18%
370 bps
12%
24%
5,133
1,167
22.7%
548
619
5,357
1,337
25.0%
624
713
4%
15%
230 bps
14%
15%
11.1%
13.6%
250 bps
12.1%
13.3%
120 bps
Contribution and margin • Led by improved mix (including higher share of SSC(1)), and favorable input cost
EBITDA • Driven by higher contribution
(1) SSC: Super Specialty Chemicals (specialty chemicals sales externally)
30
FY26 Outlook and Guidance
UPL Limited | Q2FY26 Summary and FY26 Outlook
Q2 PATMI up by ~₹1,000 cr, led by broad-based EBITDA growth and financial discipline; Strong H1 with planned de-gearing; FY26 EBITDA guidance upgraded
Q2FY26 Key takeaways
FY26 Outlook
▪ Robust growth in revenue +8% vs. LY
▪ Strong accretion in contribution margin at ~42% (+420 bps)
▪ EBITDA at >₹2,200 cr (+40%: broad-based);
EBITDA margin at >18% (+410 bps)
▪ PATMI improved by a significant ~₹1,000 cr vs. LY
▪ Net working capital lower by ~5 days vs. LY
▪ Net debt lower by >$600Mn vs. LY; adj. for perpetual bond redemption, lower by ~$1.0Bn; improved gearing ratios
• Crop protection
Mix led margin accretion and volume growth despite headwinds; normal-to-low channel inventory, NPLs
• Advanta
Strong FY26 outlook, growth with EBITDA accretion
• SUPERFORM
Strong positives for SSC segment, with margin expansion
On strong trajectory with positive FY26 outlook; upgrading guidance
32
UPL Limited
FY26 Upgraded Guidance
Revenue Growth vs. LY
EBITDA Growth vs. LY
Earlier
4–8%
10–14%
Now
4–8%
12–16%
33
Our resilient core comes from state-of-the art backward integrated manufacturing and world class R&D capabilities
34
UPL Limited | Manufacturing and R&D capabilities
1
2
Manufacturing Facilities + Capabilities
R&D Capabilities
35
UPL’s Global Presence and Manufacturing Facilities
1
2
Enables effective catering to growers’ unique needs in each market, offering bespoke solutions enhancing agricultural results, driving success
43 Global Manufacturing Facilities
USA
Mexico
Costa Rica
Colombia
UK
France
Belgium
Ivory Coast
Korea
China
India
Vietnam
Indonesia
Brazil
Argentina
South Africa
Field Station
R&D Chemistry
New Agtech / NPP
Manufacturing Facility
36
India Manufacturing | Core Pillar of our Strength
1
2
State-of-the-art Manufacturing Facilities with Advanced Synthesis Capabilities
Strategically Located Facilities for Global Agchem and Super-Specialty Businesses
Backed by Advanced Synthesis Capabilities
Halol, Gujarat Agrochemicals Phosgene Derivatives
Kalol, Gujarat Agrochemicals
Dahej, Gujarat Agrochemicals Cyanide Derivatives Phosgene Derivatives
Vapi, Gujarat Agrochemicals Phosphorus Derivatives
Tarapur, Maharashtra Agrochemicals
Bangalore, Karnataka Fermutation
Chandigarh, Punjab (Kudos) Pharma, F&B, and Cyanide Derivatives
Jhagadia, Gujarat Agrochemicals Acrolein H2S Chemistry Phosphorus Derivatives
Haldia, West Bengal Phosphorus Derivatives
Ankleshwar, Gujarat • Plant I
• Agrochemicals • Phosphorus Derivatives • Others
• Plant II
• Agrochemicals • Lubricants
Fermutation
Pharma & Food Chemicals
Agro and Specialty Chemicals
Cyanation Phosgenation Hydrogenation
Sulphurization Phosphorization Esterification
Electrolysis Ozonation Thermal Cracking
1
6
2
Reaction Chemistries
5
3
4
Grignard Nitration Amination
Isomerization Acylation Oxidation
Chlorination; Bromination Hydrolysis
Manufacturing Excellence – Key Highlights
Fully funded common Infrastructure to be leveraged for manufacturing agrochemical products as well as high margin Specialty Chemicals
Team of 70+ Engineers and 30+ data scientists driving debottlenecking and cost reduction initiatives
Extensive vertical integration in key chemistries
37
Focus on Operational Excellence
1
2
Dedicated Teams For Continuous Optimization Initiatives, Sustainable Growth
Maxpro
Maxpro+
Energy Cell
Commissioning
Green Cell
1
2
3
4
5
Yield, Quality, RM Consumptions, Solvent Recovery, Capacity, Process intensification
Improvement of OEE(2), Variability Reduction, Data analytics, Lean manufacturing
Energy optimization, Environment footprint reduction, Renewable energy
Safe and first-time right start-up of new projects.
Works on sustainable and new tech for water and waste management
• Labs Equipped with
• Data Analysis Using
Software • CFD(1) • Aspen • Heat Recovery • Pilot Plant Facility
• Minitab • Python • R Coding
• Driving Lighthouse
Project with McKinsey
•
•
Installation of Heat recovery systems, online condenser cleaning systems Increased share of renewable energy from 30% to 50% by FY26
• Safe Start-up • Faster Stabilization • Qualified First Batch • Excellence in Achieving Environmental Norms
• State-of-the-art
laboratories at Jhagadia and Vapi are capable in doing treatability study and testing of wastewater characteristics
a e r A s u c o F
s e i t i l i
b a p a C
(1) CFD stands for Computational Fluid Dynamics; (2) OEE stands for Overall Equipment Effectiveness
38
Safety | Critical Foundation For A Successful Manufacturing Asset
1
2
Robust Safety Framework: Validated by MNCs and Recognized Agencies
Adopted Safety as a Value: Robust Procedures in Place
…Validated by key agencies
TRFR(1)
ERT – Employees trained at all sites in fire fighting, rescue operations, first aid
Safety talk in the beginning of each shift
Implemented robust investigative procedures for all deviations and a 5S system
On-time reporting for minor incidents, near-miss incidents and defined actions steps to aid prevention
Recognized Agencies
Behavior based safety management and training
HAZOP analysis for key manufacturing processes
Undergoing cultural safety transformation supported and validated by external consultants
FY23
0.29
FY24
0.24
FY25
0.22
Continuous improvement in TRFR over last three years Among industry leaders in safety
Awards and Accolades for Safety and Sustainability
Frost and Sullivan Gold Award for Excellence in Manufacturing Practices
National Award for Manufacturing Competitiveness (NAMC) ‘Gold’ Medal from IRIM
Golden Peacock safety and environment awards – Jhagadia, Jammu plant
Awarded the ‘Think CSR’ Star Award 2019 for contribution to Urban Environment
(1) TRFR = Total Recordable Frequency Rate = Total Recordable Injuries divided by Total Manhours Worked multiplied by 2,00,000
39
Critical Focus on Sustainability
1
2
UPL’s Operations are Globally Recognised for Sustainable Performance
Stellar Track record of Sustainability Performance
Recognized by Leading Global Sustainability Benchmarks
SBTi Verified Target
Rated 1st Among Agrochemicals
49%▼
52%▼
Reduction in water consumption intensity* from baseline FY2019–20
Reduction in waste disposal intensity* from baseline FY2019–20
38%▼
Reduction in Carbon emission intensity from Baseline FY20
56%▲
Electric power from renewable sources at our two largest manufacturing plants
3%▼
4.95 Lakh+▲
Dependency on ground water, reduced vs. LY
Mangroves saplings have been planted spread across 250 acres
Logo Holder of RC and FTSE4Good
Listed in CDP Leaderboard
Endorsed CEO Water Mandate
Committed for Ten Principles of the UNGC
Committed for WBCSD Zero Wastewater Pollution
Unparalleled Sustainability Performance: Consistently recognized for Excellence by World-leading Global Benchmarks
* Intensity is measured in unit per MT of production
40
UPL’s Global R&D Presence
1
2
R&D-led Innovation Fuels Large Scale Production for Global Customers…
UPL R&D at a Glance
Key Focus Areas
Innovation in synthesis, formulation and process technology
USA KOP
Europe St. Malo Marseilles Ougree
Brazil
Ituverava
Mexico Saltillo
R&D Chemistry
Formulation
Synthesis
Spotlight on some of our R&D Innovations
China Hangzhou Heibei (Yoloo)
India
SUPERFORM (Specialty) Ankleshwar*
Dahej
Halol UPL (Agrochemicals)
Thane*
NPP Bengaluru
* India (Formulation)
Creating IP for products and process
Process engineering and safety data
Quality improvement and cost reduction
Environment management solutions
Vapour phase high pressure technology
Asymmetric Hydrogenation
Chiral Catalyst
Organo Phosphorus Chemistry
Phosgenation Chemistry
Cyanation Chemistry
R&D Facility Thane, Mumbai
41
“Pain-point” Driven Innovation Focus
1
2
Strong R&D Team Led Continued Innovation and Technological Upgrades, Successfully Addressing Grower Requirements
Spotlight on some of our R&D Innovations
Strong R&D Team of 262 Employees
Improve Farmer Resilience, Food Safety and Food Quality
Improve soil and plant health
• • Water conservation and improving fertilizer efficiency • Technologies to improve the yield and reduce environmental load • Finding solutions for emerging new pests and diseases •
Identifying new mode of action for food security
Develop New Technologies
• Miniaturization of process • New synthesis processes for chemicals •
Identifying and developing products from natural resources (biologicals)
Development of New Solutions for Emerging Sectors
• Pharmaceutical industry • Energy storage • Electrochemicals
• Water treatment • Paint industry • Fire retardants and others
39 PhDs
223 M. Sc and Engineers
Patent Granted >3,000
Formulations
SG
Soluble Granules
WDG
Water Dispersible Granules
SC
Suspension Concentrate
CS
Capsule Suspension
ZC
Combination of SC and CS
Areas of Innovation
Soil Treatment Zeba & mixtures
Seed Treatment Fungicide Insecticide Custom Blends
Crop Care Fungicides Insecticides / Biopesticides Herbicides / Intermediates
Post Harvest Anti-sprouting Agents Fruit Coating Agents
Specialty Chemicals Phosphorus, CS2, Phosgene, HCN, Chlorine and Caustic Bases Products
SE
Suspoemulsion
ME
Microemulsion
EW
Oil-in-water Emulsion
42
R&D Accreditations
1
2
Globally Recognised Facilities for Sustainable and Innovation Led Product Development, in Deep Collaboration with Ecosystem Stakeholders
Ensuring sustainability in our labs and facilities
Continued sustainability for reducing product costs, driving innovation, enhancing competitiveness and mitigating risks for a more sustainable future
Life Cycle Assessment
Environmental and social impact of products, processes for life span, including resource extraction, manufacturing, use, end-of-life management
Sustainable Material Usage
Prioritizing renewable and recyclable materials while exploring eco-friendly alternatives for product development
Green Chemistry and Engineering
Innovative principles of green chemistry/ engineering to minimize hazardous substances, lower waste and environmental footprint, improve energy efficiency in R&D
Social Impact
Considering social implications of our actions (e.g., labor practices, community engagement, access to essential goods and services)
Open Innovation and Collaboration
Partnering with stakeholders, e.g., academia, research institutions, to foster knowledge sharing, accelerating sustainable innovation
Circular Economy Principles
Designing products, processes that promote resource efficiency, waste reduction, material recovery
Training
Fostering a culture of continuous improvement
Well Recognized Lab Accreditations
Collaboration and Partnerships (Industry and Academia; Development Programs)
The R&D is fully compliant with the requirements of the above-mentioned management systems
43
Our performance, both financial and non-financial, are governed by strong and experienced Board
44
UPL Limited Board of Directors
Our exemplary governance is driven by a strong and experienced board…
Jai Shroff Chairman and Group CEO
Vikram Shroff Vice Chairman and Co-CEO
Hardeep Singh Non-Executive Director
Suresh Kumar Lead Independent Director
Vasant P. Gandhi Independent Director
Naina Lal Kidwai Independent Director
M. V. Bhanumathi Independent Director
Usha Rao Monari Independent Director
Santosh Kumar Mohanty Independent Director
Raj Tiwari Whole-time Director
45
UPL Corp Board of Directors
Anchored by industry veterans and independent directors at each platform
Jai Shroff Chairman
Vikram Shroff Non-Executive Director
Davor Pisk Independent Director
Jerome Peribere Independent Director
Kabir Mathur Nominee Director, ADIA-TPG
Mike Frank Chief Executive Officer
Paul Walsh Independent Director
Peter Scala Independent Director
Puneet Bhatia Nominee Director, ADIA-TPG
Roberta Bowman Independent Director
Stephen Dyer Independent Director
Usha Rao Monari Independent Director
Uttam Danayah Non-Executive Director
46
UPL SAS Board of Directors
Anchored by industry veterans and independent directors at each platform
Jai Shroff Chairman
Vikram Shroff Non-Executive Director
Puneet Bhatia Nominee Director, ADIA-TPG
Nawal Saini Nominee Director, Brookfield
M. V. Bhanumathi Independent Director
Usha Rao Monari Independent Director
Ravishankar Cherukuri Chief Executive Officer
47
Advanta Board of Directors
Anchored by industry veterans and independent directors at each platform
Jai Shroff Chairman
Vikram Shroff Non-Executive Director
Rajan Gajaria Vice Chairman
Gaurav Trehan Nominee Director, KKR
Utsav Mitra Nominee Director, Alpha Wave
Davor Pisk Independent Director
Usha Rao Monari Independent Director
Agnes Kalibata Independent Director
Purvi Mehta Independent Director
Santosh Kumar Mohanty Independent Director
T. Raja Independent Director
Bhupen Dubey Chief Executive Officer
48
SUPERFORM Board of Directors
Anchored by industry veterans and independent directors at each platform
Jai Shroff Chairman
Vikram Shroff Non-Executive Director
Raj Tiwari Chief Executive Officer
Suresh Kumar Independent Director
M. V. Bhanumathi Independent Director
Hardeep Singh Non-Executive Director
K. R. Srivastava Executive Director
49
UPL Limited | Leadership Team
Supplemented by a passionate and experienced global leadership team
Jai Shroff Chairman and Group CEO UPL Limited
Vikram Shroff Vice Chairman and Co-CEO UPL Limited
Toshan Tamhane Chief Operating Officer UPL Limited
Bikash Prasad Group CFO UPL Limited
Rajan Gajaria Vice Chairman Advanta
Mike Frank Chief Executive Officer UPL Corp
Ravi Cherukuri Chief Executive Officer UPL SAS
Bhupen Dubey Chief Executive Officer Advanta
Raj Tiwari Chief Executive Officer SUPERFORM
Sagar Kaushik President Corporate Affairs UPL Limited
Farokh Hilloo Chief Commercial Officer UPL Corp
Ashish Dobhal Global Sales Head UPL Corp
Sanjay Singh Global CHRO UPL Corp
Paresh Talati Head of Chemistry R&D UPL Limited
Sujoy Mazumdar Group General Counsel UPL Limited
Sandeep Deshmukh Group Company Secretary and Compliance Officer, UPL Limited
50
Thank You
For more details, please connect with
Anurag Gupta anurag.gupta@upl-ltd.com